Furthermore, the treatment of MCF-7 human breast cancer cells with ATRA, resulted in substantial inhibition of the expression and activity of the pro-MMP2 enzyme as well as a significant induction in TIMP2 protein expression [49]. The gene discussed is TIMP2; the disease is breast carcinoma.